
Cutera CUTR
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Cutera Langfristige Verbindlichkeiten 2011-2026 | CUTR
Langfristige Verbindlichkeiten Jährlich Cutera
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 430 M | 430 M | - | - | 9.17 M | 3.63 M | 3.03 M | 2.46 M | 3.05 M | 5.42 M | 5.76 M | 3.8 M | 2.77 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 430 M | 2.46 M | 81.8 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 7.25 | -8.17 % | $ 521 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.97 | - | $ 137 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 13.48 | -4.13 % | $ 1.93 B | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.08 | 0.37 % | $ 152 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 299.07 | -2.23 % | $ 8.44 B | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 41.06 | -3.54 % | $ 6.12 K | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 78.26 | 3.65 % | $ 115 B | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 109.11 | 0.84 % | $ 190 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 12.43 | -6.61 % | $ 336 M | ||
|
CONMED Corporation
CNMD
|
877 M | $ 40.63 | 1.75 % | $ 1.25 B | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
161 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
8.87 K | $ 28.95 | -0.96 % | $ 245 M | ||
|
InMode Ltd.
INMD
|
12 M | $ 14.77 | -1.66 % | $ 1.17 B | ||
|
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
2.44 M | $ 6.35 | -6.89 % | $ 180 M | ||
|
Align Technology
ALGN
|
184 M | $ 176.77 | 9.59 % | $ 13.2 B | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.54 | 0.11 % | $ 122 M | ||
|
Globus Medical
GMED
|
18.2 M | $ 87.55 | 0.56 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 10.94 | -1.26 % | $ 842 M | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 66.7 | -3.52 % | $ 1.88 B | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.45 | 0.69 % | $ 23.4 M | ||
|
IRadimed Corporation
IRMD
|
4.76 M | $ 94.23 | 0.4 % | $ 1.19 B | ||
|
Integer Holdings Corporation
ITGR
|
1.02 B | $ 85.94 | 0.49 % | $ 2.89 B | ||
|
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.67 | 0.3 % | $ 36.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
84.7 M | $ 16.64 | -1.54 % | $ 384 M |